Zydus Lifesciences (ZYDUSLIFE) — Board Meeting

Zydus Lifesciences held its 30th AGM on August 12, 2025, with 74.97% shareholder participation. The board declared a ₹11 dividend per share for FY2025 and reported strong performance with EPS of ₹57.39 vs ₹34 prior year. Key concerns emerged: 25 of 49 subsidiaries are loss-making, with over ₹20,000 crores invested, including ₹3,000 crores in VTEC and ₹6,600 crores in Zydus Pharmaceuticals. Management noted FDA observations at the Ahmedabad oncology plant but expects no material forward impact. Strategic focus remains on vaccines, biologics, and MedTech expansion.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this board meeting affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 24 September 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 24 September 2025

POWERGRID Power Grid Corporation of India Limited Announcement SBICARD SBI Cards and Payment Services Limited Corporate Action TATASTEEL Tata Steel Limited Announcement WIPRO Wipro Limited Corporate Action PIDILITIND Pidilite Industries Limited Corporate Action RECLTD REC Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.